Hospital of South West Jutland   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Denmark

Organization Overview

First Clinical Trial
2012
NCT01571609
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

Claus Bogh Juhl | Hospital of South Western Jutland | Hospital of South West Jutland | Hospital of South West Jutland, Esbjerg, Denmark | Hospital, Southwest Jytland | Mette Munk Lauridsen | Palliative Team,Hospital of South West Jutland | Palliative Team, South West Jutland Hospital | Research Unit of Health Sciences, Hospital of South West Jutland | Stinus Gadegaard Hansen

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 4)

Infections (Phase 4)

Lung Diseases (Phase 4)

Lung Diseases, Obstructive (Phase 4)

Multiple Sclerosis (Phase 3)

Multiple Sclerosis, Chronic Progressive (Phase 3)

Multiple Sclerosis, Relapsing-Remitting (Phase 3)

Pulmonary Disease, Chronic Obstructive (Phase 4)

Sclerosis (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 13
  • # of Trial APIs: 21